Recital 27, Decision_act (EU) 2004/104

In forcesince 27 Nov 2002

Following the merger Aventis has increasingly focused on its pharmaceutical activitities. Other parts of the business have been sold off. Of particular importance was the sale of Aventis Crop Sciences to Bayer in 2002.